Asahi Kasei Medical
  • Site Map
  • Contact Us
  • Loading
  • Font size: Small
  • Font size: Medium
  • Font size: Large
  • Home
  • Our Approach to Business
  • Corporate Information
  • News
  • Products
  • Patients and Families

Home > Products > Therapeutic Apheresis > Product Line > Rheofilter ER

Rheofilter ER: Plasma component separator specifically designed for rheopheresis to treat microcirculatory disorders

Features

Sharp cut-off curve

Removal of high molecular weight proteins

Gamma sterilized /ETO free

Rheofilter ER is used as part of an extracorporeal double filtration (membrane differential filtration) system in combination with a plasma separator (Plasmaflo) for selective extracorporeal plasma therapy, e.g. Rheopheresis.

Trademark
Rheofilter is a trademark of Asahi Kasei Medical Co., Ltd.

Download

Rheofilter ER

Therapies

Equipment

Contact Us

Please feel free to send us any questions you may have about our products and support.

Contact Us

Related Products

Note: It might be required in your country that medical devices shall be officially registered and/or approved by an authorized organization. Please contact our representative in your region or contact us to confirm whether the listed products are approved for use. These information may contain general information on medical-related topics and is not meant to provide specialist advice or instructions concerning the products and services sold by Asahi Kasei Medical. Please contact us directly for special inquiries. You should not use this information for diagnosing a health problem or disease but should always consult your own physician.Contact us

Top of page

About therapeutic apheresis
Plasmapheresis
Therapeutic plasmapheresis is an extracorporeal blood purification technique designed for the removal of pathogenic substances from the plasma of patients.
Continuous Renal Replacement Therapy (CRRT)
Continuous Renal Replacement Therapy (CRRT) is a slow and continuous extracorporeal blood purification therapy.
Leukocytapheresis (LCAP)
LCAP is an abbreviation for leukocytapheresis. In LCAP therapy, the leukocytes which are involved in inflammation are eliminated from the blood by extracorporeal treatment unit.
References
Therapeutic apheresis technical training
Education & training
We offer supervision regarding launch of our products and technical training for each area/country.
  • Asahi Kasei Corporation
  • Terms and Conditions
  • Privacy Policy
  • Global